Cargando…
Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: W...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089866/ https://www.ncbi.nlm.nih.gov/pubmed/27822055 http://dx.doi.org/10.2147/VHRM.S105921 |
_version_ | 1782464308811137024 |
---|---|
author | Alhaddad, Imad A Hamoui, Omar Hammoudeh, Ayman Mallat, Samir |
author_facet | Alhaddad, Imad A Hamoui, Omar Hammoudeh, Ayman Mallat, Samir |
author_sort | Alhaddad, Imad A |
collection | PubMed |
description | BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: We conducted an observational study between May 2011 and September 2012. A total of 1,470 eligible hypertensive patients were enrolled in our study and followed up for a period of 6 months. Data were collected regarding sociodemographic, health behavior, and hypertension-related characteristics. The adherence to treatment and the quality of life were self-reported using the Morisky, Green & Levine Scale and the Hypertension Quality of Life Questionnaire. RESULTS: Our results revealed that 55.9 % of the patients were adherent to their antihypertensive medication. Older age was associated with better adherence, whereas being divorced or widowed, having a poorer quality of life, and being classified as having stage 1 or 2 hypertension at the end of the study were all associated with poorer adherence. CONCLUSION: Efforts should be exerted on all levels in order to increase the adherence to anti-hypertensive treatment through the implementation of educational campaigns. |
format | Online Article Text |
id | pubmed-5089866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50898662016-11-07 Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence Alhaddad, Imad A Hamoui, Omar Hammoudeh, Ayman Mallat, Samir Vasc Health Risk Manag Original Research BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: We conducted an observational study between May 2011 and September 2012. A total of 1,470 eligible hypertensive patients were enrolled in our study and followed up for a period of 6 months. Data were collected regarding sociodemographic, health behavior, and hypertension-related characteristics. The adherence to treatment and the quality of life were self-reported using the Morisky, Green & Levine Scale and the Hypertension Quality of Life Questionnaire. RESULTS: Our results revealed that 55.9 % of the patients were adherent to their antihypertensive medication. Older age was associated with better adherence, whereas being divorced or widowed, having a poorer quality of life, and being classified as having stage 1 or 2 hypertension at the end of the study were all associated with poorer adherence. CONCLUSION: Efforts should be exerted on all levels in order to increase the adherence to anti-hypertensive treatment through the implementation of educational campaigns. Dove Medical Press 2016-10-27 /pmc/articles/PMC5089866/ /pubmed/27822055 http://dx.doi.org/10.2147/VHRM.S105921 Text en © 2016 Alhaddad et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Alhaddad, Imad A Hamoui, Omar Hammoudeh, Ayman Mallat, Samir Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title | Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title_full | Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title_fullStr | Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title_full_unstemmed | Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title_short | Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence |
title_sort | treatment adherence and quality of life in patients on antihypertensive medications in a middle eastern population: adherence |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089866/ https://www.ncbi.nlm.nih.gov/pubmed/27822055 http://dx.doi.org/10.2147/VHRM.S105921 |
work_keys_str_mv | AT alhaddadimada treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence AT hamouiomar treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence AT hammoudehayman treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence AT mallatsamir treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence |